KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Revenue (2016 - 2025)

Historic Revenue for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $2.3 billion.

  • Biogen's Revenue fell 714.14% to $2.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $9.9 billion, marking a year-over-year increase of 221.89%. This contributed to the annual value of $9.9 billion for FY2025, which is 221.89% up from last year.
  • Per Biogen's latest filing, its Revenue stood at $2.3 billion for Q4 2025, which was down 714.14% from $2.5 billion recorded in Q3 2025.
  • Biogen's Revenue's 5-year high stood at $2.8 billion during Q3 2021, with a 5-year trough of $2.3 billion in Q4 2025.
  • Its 5-year average for Revenue is $2.5 billion, with a median of $2.5 billion in 2022.
  • Per our database at Business Quant, Biogen's Revenue plummeted by 2462.52% in 2021 and then soared by 732.69% in 2025.
  • Biogen's Revenue (Quarter) stood at $2.7 billion in 2021, then fell by 6.94% to $2.5 billion in 2022, then fell by 6.2% to $2.4 billion in 2023, then grew by 2.87% to $2.5 billion in 2024, then fell by 7.14% to $2.3 billion in 2025.
  • Its Revenue stands at $2.3 billion for Q4 2025, versus $2.5 billion for Q3 2025 and $2.6 billion for Q2 2025.